CompaniesAtonco
Atonco logo

Atonco

active
Saint Herblain, France
Founded 2019
Website
About

Antibody Therapies

Areas of Focus

Categories

Biologics & BiopharmaceuticalAntibody
Clinical Trials (1)
View all

Total Trials

1

As Lead Sponsor

0

As Collaborator

1

Total Enrollment

6

By Phase

EARLY_PHASE1: 1

By Status

COMPLETED: 1
Clinical Trials Pipeline1 trial
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2020
2021
2022
2023
Today
NCT04897763
Hover over trial bars to see details

Recent Trials

NCT04897763Collaborator
Assessment of safEty, Tolerability, Radiation Dosimetry, and Imaging Properties of 89Zr-labeled giRenTuximab (89Zr-Girentuximab) in patIents With Non-musclE-iNvasive Bladder CancEr (NMIBC)
EARLY_PHASE1Completed
6 participants
Started: Oct 1, 2021 · Completed: Sep 26, 2022
Locations (1)
Headquarters
Saint Herblain, France
Map

Loading map...